Company page

Greenwich Lifesciences, Inc.

Greenwich Lifesciences, Inc. (GLSI) is a public company based in the United States with a market capitalization of approximately $190.5 million. The company focuses on developing innovative therapies in the healthcare sector. As a publicly traded entity, it is subject to regulatory oversight and provides transparency to its investors.

GLSI:NASDAQUpdated July 24, 2026
Greenwich Lifesciences, Inc. logo
Ticker
GLSI:NASDAQ
Asset type
Stock
Market cap
$190.5M
Sector
Health Technology
Industry
Biotechnology
Exchange
NASDAQ
Currency
USD